These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27413814)

  • 1. A case of TAFRO syndrome, a variant of multicentric Castleman's disease, successfully treated with corticosteroid and cyclosporine A.
    Takasawa N; Sekiguchi Y; Takahashi T; Muryoi A; Satoh J; Sasaki T
    Mod Rheumatol; 2019 Jan; 29(1):198-202. PubMed ID: 27413814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete resolution of TAFRO syndrome (thrombocytopenia, anasarca, fever, reticulin fibrosis and organomegaly) after immunosuppressive therapies using corticosteroids and cyclosporin A : a case report.
    Inoue M; Ankou M; Hua J; Iwaki Y; Hagihara M; Ota Y
    J Clin Exp Hematop; 2013; 53(1):95-9. PubMed ID: 23801140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.
    Saito H; Tanaka K; Fujiwara M; Iwasaki T; Numata T; Oda A; Kanno M; Tanaka M; Eiro M; Satoh M; Kazama JJ
    CEN Case Rep; 2019 Nov; 8(4):239-245. PubMed ID: 31077056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful Treatment with Cyclosporin A in Tocilizumab-resistant TAFRO Syndrome.
    Yamaga Y; Tokuyama K; Kato T; Yamada R; Murayama M; Ikeda T; Yamakita N; Kunieda T
    Intern Med; 2016; 55(2):185-90. PubMed ID: 26781021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
    Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
    Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
    Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
    Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High proportion of TAFRO syndrome in Thai adult Castleman's disease patients: a 10-year experience.
    Owattanapanich W; Pholmoo W; Pongpruttipan T; Siritanaratkul N
    Ann Hematol; 2018 Jun; 97(6):1019-1026. PubMed ID: 29464312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
    Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
    J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.
    Ohya E; Mizutani M; Sakaguchi H; Sekine T
    Intern Med; 2016; 55(19):2861-2867. PubMed ID: 27725549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successfully treated multicentric Castleman's disease with renal thrombotic microangiopathy using rituximab and corticosteroid.
    Lee JP; Kim DK; Oh DY; Paik JH; Moon KC; Kim S; Kim YS
    Clin Nephrol; 2011 Feb; 75(2):165-70. PubMed ID: 21255547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenalitis and anasarca in idiopathic multicentric Castleman's disease.
    Chen LYC; Skinnider BF; Wilson D; Fajgenbaum DC
    Lancet; 2021 May; 397(10286):1749. PubMed ID: 33965090
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute Kidney Injury Caused by TAFRO Syndrome in a Chinese Patient: Efficacy of Long-Term Corticosteroids Combined with Bortezomib and Cyclophosphamide.
    Xia P; Zhang L; Zou M; Zhang T; Li R; Shi X; Wang J; Qin Y; Li X; Li J; Chen L
    Kidney Blood Press Res; 2020; 45(4):623-630. PubMed ID: 32492687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
    Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
    Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [TAFRO syndrome and monoclonal gammapathy: Uncommon association!].
    Naifar M; Messedi M; Elleuch A; Snoussi M; Gouiaa N; Turki M; Lahiani A; Boudawara T; Bahloul Z; Ayedi F
    Curr Res Transl Med; 2016; 64(1):43-7. PubMed ID: 27140598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery from prolonged thrombocytopenia in patients with TAFRO syndrome: case series and literature review.
    Yamaguchi Y; Maeda Y; Shibahara T; Nameki S; Nakabayashi A; Komuta K; Mizuno Y; Yagita M; Manabe Y; Morita T; Nishide M; Watanabe A; Takamatsu H; Nishida S; Hirano T; Shima Y; Narazaki M; Kumanogoh A
    Mod Rheumatol Case Rep; 2020 Jul; 4(2):302-309. PubMed ID: 33087016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
    Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HHV-8-positive Castleman's disease with rapidly progressing multiorgan failure mimicking TAFRO syndrome].
    Ide S; Ohara S; Uchida T; Inoue M; Hagihara M
    Rinsho Ketsueki; 2020; 61(10):1497-1501. PubMed ID: 33162447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical hyaline vascular-type castleman's disease with thrombocytopenia, anasarca, fever, and systemic lymphadenopathy.
    Iwaki N; Sato Y; Takata K; Kondo E; Ohno K; Takeuchi M; Orita Y; Nakao S; Yoshino T
    J Clin Exp Hematop; 2013; 53(1):87-93. PubMed ID: 23801139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.
    Tedesco S; Postacchini L; Manfredi L; Goteri G; Luchetti MM; Festa A; Gabrielli A; Pomponio G
    Exp Hematol Oncol; 2015; 4(1):3. PubMed ID: 25671135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Siltuximab Monotherapy in Tafro Syndrome: A Case Report and Review of the Literature.
    Cordero L; Aguilar-Rodríguez F; Sandino J; Alonso M; Gutiérrez E
    J Nephrol; 2023 May; 36(4):1181-1185. PubMed ID: 36652167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.